Influenza vaccine and novel adjuvants

Details Influenza vaccine and novel adjuvants Influenza vaccine and novel adjuvants

A - Human Necessities

61

K

167/123, 167/132

A61K 39/145 (2006.01) A61K 9/127 (2006.01) A61K 39/39 (2006.01) A61K 9/00 (2006.01)

Patent

CA 1337332

An influenza immunizing dosage form comprising a liposome and an antigen of Influenza, particularly the hemagglutinin or bromelain fragment, wherein said liposome and antigen are present in an immunization dose. Additionally, a dosage form, including such form particularly adapted to producing an immune response, comprising a salt form of an organic acid derivative of a sterol and an antigen wherein said organic acid derivative of a sterol and antigen are present in an immunization dose, and method of use. Further, a dosage form, including such form particularly adapted to producing an immune response, comprising dymyristoylphosphatidylcholine (DMPC)/cholesterol liposomes, optionally in an aluminum hydroxide gel, and an antigen wherein said DMPC/cholesterol and antigen are present in an immunization dose, and method of use.

609464

Affiliated with

Also associated with

Rating

Influenza vaccine and novel adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Influenza vaccine and novel adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Influenza vaccine and novel adjuvants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1169747